"10.1371_journal.pone.0078488","plos one","2013-10-14T00:00:00Z","Daniel R Zweitzig; Nichol M Riccardello; John Morrison; Jason Rubino; Jennifer Axelband; Rebecca Jeanmonod; Bruce I Sodowich; Mark J Kopnitsky; S Mark Oâ€™Hara","Research and Development, ZEUS Scientific, Raritan, New Jersey, United States of America; St. Lukes University Health Network, Bethlehem, Pennsylvania, United States of America","Conceived and designed the experiments: SMO DZ NR MK RJ JR JA. Performed the experiments: NR DZ BS. Analyzed the data: SMO DZ NR MK BS. Contributed reagents/materials/analysis tools: JM JR RJ JA DZ NR BS. Wrote the manuscript: DZ SMO NR MK RJ JM.","This study was supported by ZEUS Scientific Inc. At the time this manuscript was prepared, Daniel R. Zweitzig, Nichol M. Riccardello, Bruce I. Sodowich, Mark J. Kopnitsky, S. Mark OHara were paid employees of ZEUS Scientific Inc. The ETGA technology is the subject of the following patent application which is relevant to this study, US Patent Application No. 13/641480, entitled Methods for measuring Enzyme Activity Useful In Determining Cell Viability in Non-Purified Samples. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Daniel R Zweitzig","DRZ",9,TRUE,7,3,5,6,TRUE,TRUE,FALSE,0,NA,FALSE
